Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.

about

Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.

Item

http://www.wikidata.org/entity/Q53312576

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Quantification of epidermal gr ...... l and prognostic implications.

@en

type

Item

label

Quantification of epidermal gr ...... l and prognostic implications.

@en

prefLabel

Quantification of epidermal gr ...... l and prognostic implications.

@en

P1476

Quantification of epidermal gr ...... al and prognostic implications

@en

P2093

G Silván

http://www.w3.org/2001/XMLSchema#string

J C Illera

http://www.w3.org/2001/XMLSchema#string

M D Perez-Alenza

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Epidermal growth factor receptor as a therapeutic target in veterinary oncology.

Nuclear EGFR as a molecular target in cancer.

Emerging EGFR antagonists for breast cancer.

EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.

Epidermal growth factor enhances the malignant phenotype in canine mammary carcinoma cell lines.

P304

383-390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VCO.12174

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Felisbina L. Queiroga

L Peña

Alfredo González Gil

P577

2015-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26463704

http://www.w3.org/2001/XMLSchema#string